We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 6,741 results
  1. Amplifications of EVX2 and HOXD9-HOXD13 on 2q31 in mature cystic teratomas of the ovary identified by array comparative genomic hybridization may explain teratoma characteristics in chondrogenesis and osteogenesis

    Background

    Teratomas are a common type of germ cell tumor. However, only a few reports on their genomic constitution have been published. The study of...

    Wen-Chung Wang, Tai-Cheng Hou, ... Yen-Chein Lai in Journal of Ovarian Research
    Article Open access 21 June 2024
  2. Application of array comparative genomic hybridization (aCGH) for identification of chromosomal aberrations in the recurrent pregnancy loss

    Spontaneous abortion occurs in 8–20% of recognized pregnancies and usually takes place in the first trimester (7–11 weeks). There are many causes of...

    Katarzyna Kowalczyk, Marta Smyk, ... Beata Anna Nowakowska in Journal of Assisted Reproduction and Genetics
    Article Open access 26 January 2022
  3. Genomic technologies for detecting structural variations in hematologic malignancies

    Genomic structural variations in myeloid, lymphoid, and plasma cell neoplasms can provide key diagnostic, prognostic, and therapeutic information...

    Mi-Ae Jang in Blood Research
    Article Open access 13 February 2024
  4. Genomic testing for copy number and single nucleotide variants in spermatogenic failure

    Purpose

    To identify clinically significant genomic copy number (CNV) and single nucleotide variants (SNV) in males with unexplained spermatogenic...

    J. Hardy, N. Pollock, ... A. N. Yatsenko in Journal of Assisted Reproduction and Genetics
    Article 18 July 2022
  5. Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements

    Background

    NRG1 fusion is a promising therapeutic target for various tumors but its prevalence is extremely low, and there are no standardized testing...

    **aomei Zhang, Lin Li, ... Qing Ye in Diagnostic Pathology
    Article Open access 03 January 2024
  6. Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis

    Melanoma is the leading cause of death among cutaneous neoplasms. Best outcome relies on early detection and accurate pathologic diagnosis. For the...

    Jayson Miedema, Aleodor A. Andea in Modern Pathology
    Article 17 February 2020
  7. Comparative genomic characterization of melanoma of known and unknown primary

    Background

    This study aims to genomically characterize melanoma of unknown primary (MUP) in comparison to melanomas of cutaneous primary (MCP).

    ...
    E. Rassy, S. Boussios, ... N. Pavlidis in Clinical and Translational Oncology
    Article 02 May 2021
  8. Genomic landscape of Epstein–Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue

    Epstein–Barr virus (EBV)-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT lymphomas) were initially described...

    Bryan Rea, Yen-Chun Liu, ... Sarah E. Gibson in Modern Pathology
    Article 24 December 2021
  9. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients

    Background

    Human papillomavirus (HPV) has been proposed as a potential pathogenetic organism involved in prostate cancer (PCa), but the association...

    Bin Lang, Chen Cao, ... Yongji Yan in European Journal of Medical Research
    Article Open access 17 July 2023
  10. Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse

    The genomic spectrum of rhabdomyosarcoma (RMS) progression from primary to relapse is not fully understood. In this pilot study, we explore the...

    Henry de Traux de Wardin, Josephine K. Dermawan, ... Cristina R. Antonescu in npj Precision Oncology
    Article Open access 20 September 2023
  11. Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes

    Purpose

    This study aimed to explore the correlations among heavy metals concentration, histologic subtypes and molecular characteristics in patients...

    Die Mu, Hui Tang, ... Cuimin Zhu in Journal of Cancer Research and Clinical Oncology
    Article Open access 31 May 2023
  12. Terminal microdeletion of chromosome 18 in a Malaysian boy characterized with few features of typical 18q- deletion syndrome: a case report

    Background

    The 18q- deletion syndrome is a rare congenital chromosomal disorder caused by a partial deletion of the long arm of chromosome 18. The...

    Azli Ismail, Fadly Ahid, ... Zubaidah Zakaria in Journal of Medical Case Reports
    Article Open access 10 June 2023
  13. Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary–pancreatic cancers

    Comprehensive genomic profiling based on next-generation sequencing has recently been used to provide precision medicine for various advanced...

    Yoshinori Ozono, Hiroshi Kawakami, ... Souichiro Ogawa in Journal of Gastroenterology
    Article Open access 12 September 2023
  14. Race and prostate cancer: genomic landscape

    In the past 20 years, new insights into the genomic pathogenesis of prostate cancer have been provided. Large-scale integrative genomics approaches...

    Camilo Arenas-Gallo, Jude Owiredu, ... Jonathan E. Shoag in Nature Reviews Urology
    Article 09 August 2022
  15. Integrated genomic analyses of hepatocellular carcinoma

    Background

    Genomic alterations play important roles in the development of cancer. We explored the impact of protein-coding genes and transcriptomic...

    Ya-Sian Chang, Siang-Jyun Tu, ... Jan-Gowth Chang in Hepatology International
    Article 06 December 2022
  16. Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China

    Purpose

    Meaningful comparison of mutational landscapes across ethnic groups requires the use of standardized platform technology. We have used a...

    **aoran Liu, Andrew A. Davis, ... Massimo Cristofanilli in Breast Cancer Research and Treatment
    Article Open access 01 September 2021
  17. Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas

    Leiomyosarcoma (LMS) is a rare, aggressive, mesenchymal tumor. Subsets of LMS have been identified to harbor genomic alterations associated with...

    Nathan D. Seligson, Joy Tang, ... James L. Chen in npj Precision Oncology
    Article Open access 25 April 2022
  18. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients

    Primary central nervous system lymphoma (PCNSL) is an uncommon non-Hodgkin’s lymphoma with poor prognosis. This study aimed to depict the genetic...

    **anggui Yuan, Teng Yu, ... Wenbin Qian in Frontiers of Medicine
    Article 07 July 2023
  19. Potential biomarker signatures in male infertility: integrative genomic analysis

    Background

    Studies have attributed 50% of infertility cases to male infertility, 15% of which is caused by idiopathic genetic factors. Currently, no...

    Devalina Junahar, Rinesia Dwiputri, ... Suyanto Suyanto in Egyptian Journal of Medical Human Genetics
    Article Open access 26 March 2024
  20. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

    Recent clinical development of KRAS inhibitors has heightened interest in the genomic landscape of KRAS -altered cancers. We performed a pan-cancer...

    Jessica K. Lee, Smruthy Sivakumar, ... Zhen Shi in npj Precision Oncology
    Article Open access 09 December 2022
Did you find what you were looking for? Share feedback.